Cover Image
市場調查報告書

Aridis Pharmaceuticals LLC的產品平台分析

Aridis Pharmaceuticals LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 317882
出版日期 內容資訊 英文 30 Pages
訂單完成後即時交付
價格
Back to Top
Aridis Pharmaceuticals LLC的產品平台分析 Aridis Pharmaceuticals LLC - Product Pipeline Review - 2015
出版日期: 2015年05月20日 內容資訊: 英文 30 Pages
簡介

Aridis Pharmaceuticals LLC 是總公司位於美國的生物科技企業,擁有黃色葡萄球菌,綠色膿菌,鮑氏不動桿菌,呼吸道融合病毒(RSV)等主要的人類病原體的單株抗體,正進開發抗體醫藥品及疫苗。

本報告提供Aridis Pharmaceuticals LLC 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Aridis Pharmaceuticals LLC 基本資料

  • Aridis Pharmaceuticals LLC 概要
  • 主要資訊
  • 企業資料

Aridis Pharmaceuticals LLC :R&D概要

  • 主要的治療範圍

Aridis Pharmaceuticals LLC :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Aridis Pharmaceuticals LLC :開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Aridis Pharmaceuticals LLC :藥物簡介

  • panobacumab
  • tosatoxumab
  • Panaecin
  • Aerucin
  • AR-104
  • AR-201
  • AR-401

Aridis Pharmaceuticals LLC :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Aridis Pharmaceuticals LLC :最新的開發平台趨勢

Aridis Pharmaceuticals LLC :開發暫停中的計劃

Aridis Pharmaceuticals LLC :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07058CDB

Summary

Global Markets Direct's, 'Aridis Pharmaceuticals LLC - Product Pipeline Review - 2015', provides an overview of the Aridis Pharmaceuticals LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aridis Pharmaceuticals LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Aridis Pharmaceuticals LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Aridis Pharmaceuticals LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Aridis Pharmaceuticals LLC's pipeline products

Reasons to buy

  • Evaluate Aridis Pharmaceuticals LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Aridis Pharmaceuticals LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Aridis Pharmaceuticals LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Aridis Pharmaceuticals LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aridis Pharmaceuticals LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Aridis Pharmaceuticals LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Aridis Pharmaceuticals LLC Snapshot
    • Aridis Pharmaceuticals LLC Overview
    • Key Information
    • Key Facts
  • Aridis Pharmaceuticals LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Aridis Pharmaceuticals LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Aridis Pharmaceuticals LLC - Pipeline Products Glance
    • Aridis Pharmaceuticals LLC - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Aridis Pharmaceuticals LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Aridis Pharmaceuticals LLC - Drug Profiles
    • panobacumab
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • tosatoxumab
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Aerucin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-104
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-401
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Panaecin
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Aridis Pharmaceuticals LLC - Pipeline Analysis
    • Aridis Pharmaceuticals LLC - Pipeline Products by Target
    • Aridis Pharmaceuticals LLC - Pipeline Products by Route of Administration
    • Aridis Pharmaceuticals LLC - Pipeline Products by Molecule Type
    • Aridis Pharmaceuticals LLC - Pipeline Products by Mechanism of Action
  • Aridis Pharmaceuticals LLC - Recent Pipeline Updates
  • Aridis Pharmaceuticals LLC - Dormant Projects
  • Aridis Pharmaceuticals LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Aridis Pharmaceuticals LLC, Key Information
  • Aridis Pharmaceuticals LLC, Key Facts
  • Aridis Pharmaceuticals LLC - Pipeline by Indication, 2015
  • Aridis Pharmaceuticals LLC - Pipeline by Stage of Development, 2015
  • Aridis Pharmaceuticals LLC - Monotherapy Products in Pipeline, 2015
  • Aridis Pharmaceuticals LLC - Phase II, 2015
  • Aridis Pharmaceuticals LLC - Phase I, 2015
  • Aridis Pharmaceuticals LLC - Preclinical, 2015
  • Aridis Pharmaceuticals LLC - Pipeline by Target, 2015
  • Aridis Pharmaceuticals LLC - Pipeline by Route of Administration, 2015
  • Aridis Pharmaceuticals LLC - Pipeline by Molecule Type, 2015
  • Aridis Pharmaceuticals LLC - Pipeline Products by Mechanism of Action, 2015
  • Aridis Pharmaceuticals LLC - Recent Pipeline Updates, 2015
  • Aridis Pharmaceuticals LLC - Dormant Developmental Projects,2015

List of Figures

  • Aridis Pharmaceuticals LLC - Pipeline by Top 10 Indication, 2015
  • Aridis Pharmaceuticals LLC - Pipeline by Stage of Development, 2015
  • Aridis Pharmaceuticals LLC - Monotherapy Products in Pipeline, 2015
  • Aridis Pharmaceuticals LLC - Pipeline by Top 10 Target, 2015
  • Aridis Pharmaceuticals LLC - Pipeline by Top 10 Route of Administration, 2015
  • Aridis Pharmaceuticals LLC - Pipeline by Top 10 Molecule Type, 2015
  • Aridis Pharmaceuticals LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top